By
Drug Target Review2024-01-11T16:00:52
Disruptions in TP53 and RB1 are key influencers that cause changes in the risk of mutations across chromosomes.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-07-08T07:58:00Z
Contributor Dr Nick Lynch, By Dr Raminderpal Singh
2026-07-01T13:30:00Z
Contributor Carrie Maynard and Dr Veronica Fowler
2025-05-08T10:38:52
Sponsored by Takara Bio USA
2026-06-15T11:00:00
Sponsored by Miltenyi Biotec
2026-05-25T07:00:00
Contributor Professor Neville Sanjana
2025-08-05T13:42:00
Sponsored by ICON plc., By Drug Target Review
2026-07-01T13:30:00
Contributor Carrie Maynard and Dr Veronica Fowler
2023-11-24T12:06:45
Sponsored by Quantum-Si
Site powered by Webvision Cloud